These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33437029)

  • 1. Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.
    Arita M; Watanabe S; Aoki N; Kuwahara S; Suzuki R; Goto S; Abe Y; Takahashi M; Sato M; Hokari S; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Hayashi M; Ohshima Y; Kabasawa H; Hosojima M; Koya T; Saito A; Kikuchi T
    Sci Rep; 2021 Jan; 11(1):750. PubMed ID: 33437029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.
    Hori Y; Aoki N; Kuwahara S; Hosojima M; Kaseda R; Goto S; Iida T; De S; Kabasawa H; Kaneko R; Aoki H; Tanabe Y; Kagamu H; Narita I; Kikuchi T; Saito A
    J Am Soc Nephrol; 2017 Jun; 28(6):1783-1791. PubMed ID: 28052987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.
    Humanes B; Camaño S; Lara JM; Sabbisetti V; González-Nicolás MÁ; Bonventre JV; Tejedor A; Lázaro A
    Nephrol Dial Transplant; 2017 Oct; 32(10):1645-1655. PubMed ID: 28340076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy.
    Zaballos M; Power M; Canal-Alonso MI; González-Nicolás MÁ; Vasquez-Jimenez W; Lozano-Lominchar P; Cabrerizo-Torrente P; Palencia-García N; Gago-Quiroga S; Ginel-Feito MD; Jiménez C; Lázaro A; González-Bayón L
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
    Im DS; Shin HJ; Yang KJ; Jung SY; Song HY; Hwang HS; Gil HW
    Toxicol Lett; 2017 Aug; 277():9-17. PubMed ID: 28549670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer.
    Sun Z; Xu S; Cai Q; Zhou W; Jiao X; Bao M; Yu X
    Life Sci; 2020 Dec; 263():118672. PubMed ID: 33121990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effect of Cilastatin on drug-induced nephrotoxicity: a new perspective.
    Becerir T; Tokgün O; Yuksel S
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5436-5447. PubMed ID: 34533819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
    Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
    BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin.
    He L; Zhang Y; Kang N; Wang Y; Zhang Z; Zha Z; Yang S; Xu Q; Liu Y
    Phytomedicine; 2019 Mar; 56():136-146. PubMed ID: 30668334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer.
    Lee CK; Park KK; Lim SS; Park JH; Chung WY
    Biol Pharm Bull; 2007 Nov; 30(11):2191-5. PubMed ID: 17978499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
    Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
    Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
    Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity.
    Wei J; Chen X; Li Q; Chen J; Khan N; Wang B; Cheng JW; Gordon JR; Li F
    Oncol Rep; 2014 Apr; 31(4):1599-604. PubMed ID: 24482222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.